BDNF and Alzheimer disease: A clinical trial in AD patients showed a 36% increase in brain-derived neurotrophic factor (BDNF), a decrease in IL-1β, and an increase in the antioxidant superoxide dismutase (SOD), which may improve cognitive function [116].